发表主题
论坛首页 推荐主题 主题专辑 爱医培训 爱医杂志 签约作者 荣誉勋章 排行榜 我的主页
查看: 2178|回复: 0
打印 上一主题 下一主题

[药分] 美国FDA药品分析方法学验证指南中英文对照

[复制链接]
跳转到指定楼层
1# 楼主
发表于 2013-3-8 17:08 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式

马上注册,结交更多好友,享用更多功能,让你轻松玩转社区。

您需要 登录 才可以下载或查看,没有帐号?注册

x

I. I***ODUCTION

This guidance provides recommendations to applicants on submitting **ytical procedures, validation data, and samples to support the documentation of the identity, strength, quality, purity, and potency of drug substances and drug products.

1. 绪论

本指南旨在为申请者提供建议,以帮助其提交分析方法,方法验证资料和样品用于支持原料药和制剂的认定,剂量,质量,纯度和效力方面的文件。

This guidance is intended to assist applicants in assembling ***rmation, submitting samples, and presenting data to support **ytical methodologies. The recommendations apply to drug substances and drug products covered in new drug applications (NDAs), abbreviated new drug applications (ANDAs), biologics license applications (BLAs), product license applications (PLAs), and supplements to these applications.

本指南旨在帮助申请者收集资料,递交样品并资料以支持分析方法。这些建议适用于NDA,ANDA,BLA,PLA及其它们的补充中所涉及的原料药和制剂。

The principles also apply to drug substances and drug products covered in Type II drug master files (DMFs). If a different approach is chosen, the applicant is encouraged to discuss the matter in advance with the center with product  jurisdiction to prevent the expenditure of resources on preparing a submission that may later be determined to be unacceptable.

尊重著作权人合法权益,该附件版权审核中
美国FDA分析方法验证指南中英文对照.rar (50.09 KB, 下载次数: 0)

您需要登录后才可以回帖 登录 | 注册

本版积分规则

Archiver|手机版|关于我们|隐私保护|版权保护|小黑屋|爱爱医 ( 粤ICP备2023094852号 )

GMT+8, 2024-5-1 07:08

Powered by Discuz! X3.1

© 2001-2013 Comsenz Inc.